Home
Journals
Adipocyte
American & Russian Bioscience
Artificial DNA: PNA & XNA
Autophagy
Bacteriophage
BioArchitecture
Bioengineered
Biomatter
Cancer Biology & Therapy
Cell Adhesion & Migration
Cell Cycle
Cellular Logistics
Channels
Chimerism
Communicative & Integrative Biology
Dermato-Endocrinology
Disaster Health
Endocrine Disruptors
Epigenetics
Fly
GM Crops & Food
Gut Microbes
h bioscience
Human Vaccines & Immunotherapeutics
Immunomics
IntraVital
Intrinsically Disordered Proteins
Islets
JAK-STAT
Journal of Interventional Gastroenterology
mAbs
Mobile Genetic Elements
Nucleus
OncoImmunology
Organogenesis
Plant Signaling & Behavior
Prion
Rare Diseases
RNA Biology
Small GTPases
Spermatogenesis
Systems Biomedicine
Tissue Barriers
Transcription
Translation
Virulence
Worm
Books
Intelligence Unit
Special Books
Vademecum Medical Handbooks
Madame Curie Database
Contact
Support
For Librarians
iPad
Login
by Author
by Title
Advanced
HV & I Home
Editorial Board
Subscribe
Search
Archive
Online First
Contact
For Authors
eTOC Alerts
RSS Feeds
Editor's Corner
Letter from the Editor
Downloads and Tools
Article PDF
73.18 KB PDF document
This is an open access article.
Print this page
Email this page
Recipient's Email:
Article Citation
RIS
MARC (XML)
FULL CITATION (TXT)
Share on Facebook
Volume 8, Issue 9
September 2012
Page 1167
http://dx.doi.org/10.4161/hv.22148
Authors
: Ronald Ellis and Eva M. Riedmann
View affiliations
Hide affiliations
Ronald Ellis
Corresponding author:
rellis@landesbioscience.com
Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel
Eva M. Riedmann
Acquisitions Editor; Landes Bioscience; Vienna, Austria
Received:
August 22, 2012;
Accepted:
August 22, 2012;
Published Online:
September 1, 2012
Preview:
Show Full Text
Advertisements